TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Shire Biotech Norway AS
Closing information (x1000 EUR)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
2,154
|
1,493
|
1,264 |
Financial expenses |
3
|
0
|
4 |
Earnings before taxes |
103
|
71
|
56 |
Total assets |
680
|
521
|
327 |
Current assets |
678
|
518
|
326 |
Current liabilities |
438
|
359
|
201 |
Equity capital |
242
|
163
|
125 |
- share capital |
11
|
10
|
11 |
Employees (average) |
6
|
5
![]() |
5 |
Shareholders | 0 | 0 | 3 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
35.6%
|
31.3%
|
38.2% |
Turnover per employee |
359
|
299
|
253 |
Profit as a percentage of turnover |
4.8%
![]() |
4.8%
|
4.4% |
Return on assets (ROA) |
15.6%
|
13.6%
|
18.3% |
Current ratio |
154.8%
|
144.3%
|
162.2% |
Return on equity (ROE) |
42.6%
|
43.6%
|
44.8% |
Change turnover |
583
|
296
|
630 |
Change turnover % |
37%
|
25%
|
99% |
Chg. No. of employees |
1
|
0
|
2 |
Chg. No. of employees % |
20%
|
0%
|
67% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.